Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Zhu Lingfeng, Jin Chen
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 108

Showing 26-50 of 108 citing articles:

The recent advancement of TCR-T cell therapies for cancer treatment
Xiang Zhao, Shuai Shao, Lanxin Hu
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 5
β2-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy
Muhammad Asad Farooq, Iqra Ajmal, Xinhui Hui, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12837-12837
Open Access | Times Cited: 12
CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar
Kun Chen, Minling Liu, Jiancheng Wang, et al.
Biomolecules and Biomedicine (2023) Vol. 24, Iss. 3, pp. 465-476
Open Access | Times Cited: 11
Charting new paradigms for CAR-T cell therapy beyond current Achilles heels
Ying Li, Zhenhua Hu, Yuanyuan Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
CAR-T cell therapy in advanced thyroid cancer: from basic to clinical
Zhenhua Sun, Chaohui Wang, Yuyang Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects
Paula Ercilla-Rodríguez, Marta Sánchez‐Díez, Nicolás Alegría‐Aravena, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
Merve Kulbay, Nicolas Tuli, M. R. Mazza, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 108-108
Open Access
Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy
Shaida Ouladan, Elias Orouji
Journal of Clinical Oncology (2025)
Closed Access
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
Hadeer Mohamed Ahmed, Said S. Moselhy, Magda I. Mohamad, et al.
Annals of Hematology (2025)
Open Access
Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
Yi Hu, Yuetao Xie, Xiaodong Wang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications
Zhuan Wen, Zhang‐Zhi Song, M. S. Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 1
Closed Access
Syncytial therapeutics: Receptor-specific and direct-to-cytosol biologic drug delivery mediated by measles fusion complex
Víctor García, Casim A. Sarkar, Brenda M. Ogle
Journal of Controlled Release (2025) Vol. 380, pp. 967-975
Closed Access
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond
Zishan Yang, Boram Ha, Qinhan Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in CAR optimization strategies based on CD28
Sijin Li, Yongning Zhou, Hairong Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cutting-Edge Technologies Illuminate the Neural Landscape of Cancer: Insights into Tumor Development
Yajing Wang, Zhao‐Jun Wang, Xinyuan Mao, et al.
Cancer Letters (2025), pp. 217667-217667
Closed Access
Liposomes as Immunotherapeutic Carriers: A Game-Changer in Cancer Therapy
Sepehr Hoseinzadeh Moghaddam, Abulfazl Vatankhah, Fatemeh Oroojalian, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106847-106847
Closed Access
Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer
Shaukat Ali, Mahnoor Arshad, Muhammad Summer, et al.
Journal of Oncology Pharmacy Practice (2025)
Closed Access
CAR T Cells in Lung Cancer: Targeting Tumor-Associated Antigens to Revolutionize Immunotherapy
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access
Adoptive immune cell therapy for colorectal cancer
Chenxiao Liu, Nan Liu, Tongcun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Strategies for Altering Delivery Technologies to Optimize CAR Therapy
Lili Cao, Yingying Liu, Guimei Lin
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3206-3206
Open Access
NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
Xia Teng, Shance Li, Chaoting Zhang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Novel bioengineered drugs with immunotherapies for malignant pleural effusion: remodulate tumor immune microenvironment and activate immune system
Lu Chen, Jie Yin, Ke Xu, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104717-104717
Closed Access
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access

Scroll to top